Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
5-Amino-1MQ was developed as a research tool to selectively block NNMT in vitro and in vivo, primarily by the Watowich group at the University of Texas at Austin
These compounds work by mimicking hormones that regulate appetite and glucose metabolism, producing significant weight loss primarily through reduced food intake
methylation cycle, SAM production, and hepatic fat metabolism research Inositol (50mg) secondary messenger precursor
Some medications to watch out for include: Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL) Tirzepatide causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time
Learn more about Rivas Telehealth
Store lyophilized 5-Amino-1MQ at -20C and protect from light
